Gabapentin and pregabalin exposures reported to United States poison centers, 2012-2022.  Carter EJR, Rine NI, Kistamgari S, Hays HL, Spiller HA, Yang J, Zhu M, Smith GA.  Inj Epidemiol. 2024 Nov 1;11(1):59. doi: 10.1186/s40621-024-005...

Gabapentinoids and Risk of Hip Fracture.  Leung MTY, Turner JP, Marquina C, et al.  JAMA Netw Open. 2024;7(11):e2444488. doi:10.1001/jamanetworkopen.2024.44488 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2826109

Systematic review: The relationship between gabapentinoids, etizolam, and drug related deaths in Scotland.  Ciesluk B, Inglis DG, Parke A, Troup LJ (2024)  PLoS ONE 19(10): e0310655. doi.org/10.1371/journal.pone.0310655 https://journa...

Characteristics of Non-Therapeutic Pregabalin Users Detected by a Community Pharmacies Network in a Region of Southern Europe.  Perelló M, Rio-Aige K, Rius P, Pérez-Cano FJ, Rabanal M.  J Clin Med. 2024 Oct 6;13(19):5942. doi: 10.3390/...

Pregabalin and gabapentin-induced heart failure. Barold SS, Barold DC, Hon R, Guglin M.  Cardiol J. 2024 Oct 29. doi: 10.5603/cj.98754. Epub ahead of print. PMID: 39470187. https://journals.viamedica.pl/cardiology_journal/article/view/9875...

Experiences of misuse and symptoms of dependence among people who use gabapentinoids: A qualitative systematic review.  McNeilage AG, Sim A, Nielsen S, Murnion B, Ashton-James CE.  Int J Drug Policy. 2024 Nov;133:104605. doi: 10.1016/j...